Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

A new compound was effective for imaging prostate cancer in rats.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tadalafil and Finasteride may help treat aggressive melanoma.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The combination therapy was effective and well-tolerated, especially in young patients.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Afatinib often causes skin problems that need proactive management.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.